0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Platelet-rich Plasma Therapy Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-28J910
Home | Market Reports | Health | Pharmacy
Global Platelet rich Plasma Therapy Market Insights and Forecast to 2028

Global Platelet-rich Plasma Therapy Market Insights and Forecast to 2028

Code: QYRE-Auto-28J910
Report
January 2022
Pages:108
QYResearch
Description
Table of Content
Tables & Figures
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
Market Analysis and Insights: Global Platelet-rich Plasma Therapy Market

The global Platelet-rich Plasma Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Pure PRP accounting for % of the Platelet-rich Plasma Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Orthopedic segment is altered to an % CAGR throughout this forecast period.
China Platelet-rich Plasma Therapy market size is valued at US$ million in 2021, while the North America and Europe Platelet-rich Plasma Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Platelet-rich Plasma Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Platelet-rich Plasma Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Platelet-rich Plasma Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Platelet-rich Plasma Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Platelet-rich Plasma Therapy market.
Global Platelet-rich Plasma Therapy Scope and Market Size
Platelet-rich Plasma Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Platelet-rich Plasma Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)

Segment by Application

Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Others

BY COMPANY

Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Platelet-rich Plasma Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pure PRP
1.2.3 Leucocyte-rich PRP
1.2.4 Leukocyte-rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Platelet-rich Plasma Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Orthopedic
1.3.3 Darmatology
1.3.4 Cardiac Muscle Injury
1.3.5 Dental
1.3.6 Nerve Injury
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Platelet-rich Plasma Therapy Market Perspective (2017-2028)
2.2 Platelet-rich Plasma Therapy Growth Trends by Region
2.2.1 Platelet-rich Plasma Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Platelet-rich Plasma Therapy Historic Market Size by Region (2017-2022)
2.2.3 Platelet-rich Plasma Therapy Forecasted Market Size by Region (2023-2028)
2.3 Platelet-rich Plasma Therapy Market Dynamics
2.3.1 Platelet-rich Plasma Therapy Industry Trends
2.3.2 Platelet-rich Plasma Therapy Market Drivers
2.3.3 Platelet-rich Plasma Therapy Market Challenges
2.3.4 Platelet-rich Plasma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Platelet-rich Plasma Therapy Players by Revenue
3.1.1 Global Top Platelet-rich Plasma Therapy Players by Revenue (2017-2022)
3.1.2 Global Platelet-rich Plasma Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Platelet-rich Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Platelet-rich Plasma Therapy Revenue
3.4 Global Platelet-rich Plasma Therapy Market Concentration Ratio
3.4.1 Global Platelet-rich Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platelet-rich Plasma Therapy Revenue in 2021
3.5 Platelet-rich Plasma Therapy Key Players Head office and Area Served
3.6 Key Players Platelet-rich Plasma Therapy Product Solution and Service
3.7 Date of Enter into Platelet-rich Plasma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Platelet-rich Plasma Therapy Breakdown Data by Type
4.1 Global Platelet-rich Plasma Therapy Historic Market Size by Type (2017-2022)
4.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Type (2023-2028)
5 Platelet-rich Plasma Therapy Breakdown Data by Application
5.1 Global Platelet-rich Plasma Therapy Historic Market Size by Application (2017-2022)
5.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Platelet-rich Plasma Therapy Market Size (2017-2028)
6.2 North America Platelet-rich Plasma Therapy Market Size by Type
6.2.1 North America Platelet-rich Plasma Therapy Market Size by Type (2017-2022)
6.2.2 North America Platelet-rich Plasma Therapy Market Size by Type (2023-2028)
6.2.3 North America Platelet-rich Plasma Therapy Market Share by Type (2017-2028)
6.3 North America Platelet-rich Plasma Therapy Market Size by Application
6.3.1 North America Platelet-rich Plasma Therapy Market Size by Application (2017-2022)
6.3.2 North America Platelet-rich Plasma Therapy Market Size by Application (2023-2028)
6.3.3 North America Platelet-rich Plasma Therapy Market Share by Application (2017-2028)
6.4 North America Platelet-rich Plasma Therapy Market Size by Country
6.4.1 North America Platelet-rich Plasma Therapy Market Size by Country (2017-2022)
6.4.2 North America Platelet-rich Plasma Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Platelet-rich Plasma Therapy Market Size (2017-2028)
7.2 Europe Platelet-rich Plasma Therapy Market Size by Type
7.2.1 Europe Platelet-rich Plasma Therapy Market Size by Type (2017-2022)
7.2.2 Europe Platelet-rich Plasma Therapy Market Size by Type (2023-2028)
7.2.3 Europe Platelet-rich Plasma Therapy Market Share by Type (2017-2028)
7.3 Europe Platelet-rich Plasma Therapy Market Size by Application
7.3.1 Europe Platelet-rich Plasma Therapy Market Size by Application (2017-2022)
7.3.2 Europe Platelet-rich Plasma Therapy Market Size by Application (2023-2028)
7.3.3 Europe Platelet-rich Plasma Therapy Market Share by Application (2017-2028)
7.4 Europe Platelet-rich Plasma Therapy Market Size by Country
7.4.1 Europe Platelet-rich Plasma Therapy Market Size by Country (2017-2022)
7.4.2 Europe Platelet-rich Plasma Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size (2017-2028)
8.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type
8.2.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Platelet-rich Plasma Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application
8.3.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Platelet-rich Plasma Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region
8.4.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Platelet-rich Plasma Therapy Market Size (2017-2028)
9.2 Latin America Platelet-rich Plasma Therapy Market Size by Type
9.2.1 Latin America Platelet-rich Plasma Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Platelet-rich Plasma Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Platelet-rich Plasma Therapy Market Share by Type (2017-2028)
9.3 Latin America Platelet-rich Plasma Therapy Market Size by Application
9.3.1 Latin America Platelet-rich Plasma Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Platelet-rich Plasma Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Platelet-rich Plasma Therapy Market Share by Application (2017-2028)
9.4 Latin America Platelet-rich Plasma Therapy Market Size by Country
9.4.1 Latin America Platelet-rich Plasma Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Platelet-rich Plasma Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size (2017-2028)
10.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type
10.2.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Platelet-rich Plasma Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application
10.3.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Platelet-rich Plasma Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country
10.4.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Terumo
11.1.1 Terumo Company Details
11.1.2 Terumo Business Overview
11.1.3 Terumo Platelet-rich Plasma Therapy Introduction
11.1.4 Terumo Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.1.5 Terumo Recent Developments
11.2 Arthrex
11.2.1 Arthrex Company Details
11.2.2 Arthrex Business Overview
11.2.3 Arthrex Platelet-rich Plasma Therapy Introduction
11.2.4 Arthrex Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.2.5 Arthrex Recent Developments
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Platelet-rich Plasma Therapy Introduction
11.3.4 Zimmer Biomet Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.3.5 Zimmer Biomet Recent Developments
11.4 DePuy Synthes
11.4.1 DePuy Synthes Company Details
11.4.2 DePuy Synthes Business Overview
11.4.3 DePuy Synthes Platelet-rich Plasma Therapy Introduction
11.4.4 DePuy Synthes Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.4.5 DePuy Synthes Recent Developments
11.5 EmCyte
11.5.1 EmCyte Company Details
11.5.2 EmCyte Business Overview
11.5.3 EmCyte Platelet-rich Plasma Therapy Introduction
11.5.4 EmCyte Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.5.5 EmCyte Recent Developments
11.6 Regen Lab
11.6.1 Regen Lab Company Details
11.6.2 Regen Lab Business Overview
11.6.3 Regen Lab Platelet-rich Plasma Therapy Introduction
11.6.4 Regen Lab Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.6.5 Regen Lab Recent Developments
11.7 ISTO Biologics
11.7.1 ISTO Biologics Company Details
11.7.2 ISTO Biologics Business Overview
11.7.3 ISTO Biologics Platelet-rich Plasma Therapy Introduction
11.7.4 ISTO Biologics Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.7.5 ISTO Biologics Recent Developments
11.8 Cesca Therapeutics
11.8.1 Cesca Therapeutics Company Details
11.8.2 Cesca Therapeutics Business Overview
11.8.3 Cesca Therapeutics Platelet-rich Plasma Therapy Introduction
11.8.4 Cesca Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.8.5 Cesca Therapeutics Recent Developments
11.9 Weigao
11.9.1 Weigao Company Details
11.9.2 Weigao Business Overview
11.9.3 Weigao Platelet-rich Plasma Therapy Introduction
11.9.4 Weigao Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.9.5 Weigao Recent Developments
11.10 REV-MED
11.10.1 REV-MED Company Details
11.10.2 REV-MED Business Overview
11.10.3 REV-MED Platelet-rich Plasma Therapy Introduction
11.10.4 REV-MED Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.10.5 REV-MED Recent Developments
11.11 Nuo Therapeutics
11.11.1 Nuo Therapeutics Company Details
11.11.2 Nuo Therapeutics Business Overview
11.11.3 Nuo Therapeutics Platelet-rich Plasma Therapy Introduction
11.11.4 Nuo Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2017-2022)
11.11.5 Nuo Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Platelet-rich Plasma Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Pure PRP
    Table 3. Key Players of Leucocyte-rich PRP
    Table 4. Key Players of Leukocyte-rich Fibrin (L-PRF)
    Table 5. Global Platelet-rich Plasma Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Platelet-rich Plasma Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Platelet-rich Plasma Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Platelet-rich Plasma Therapy Market Share by Region (2017-2022)
    Table 9. Global Platelet-rich Plasma Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Platelet-rich Plasma Therapy Market Share by Region (2023-2028)
    Table 11. Platelet-rich Plasma Therapy Market Trends
    Table 12. Platelet-rich Plasma Therapy Market Drivers
    Table 13. Platelet-rich Plasma Therapy Market Challenges
    Table 14. Platelet-rich Plasma Therapy Market Restraints
    Table 15. Global Platelet-rich Plasma Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Platelet-rich Plasma Therapy Revenue Share by Players (2017-2022)
    Table 17. Global Top Platelet-rich Plasma Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platelet-rich Plasma Therapy as of 2021)
    Table 18. Ranking of Global Top Platelet-rich Plasma Therapy Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Platelet-rich Plasma Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Platelet-rich Plasma Therapy Product Solution and Service
    Table 22. Date of Enter into Platelet-rich Plasma Therapy Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Platelet-rich Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Platelet-rich Plasma Therapy Revenue Market Share by Type (2017-2022)
    Table 26. Global Platelet-rich Plasma Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Platelet-rich Plasma Therapy Revenue Market Share by Type (2023-2028)
    Table 28. Global Platelet-rich Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Platelet-rich Plasma Therapy Revenue Share by Application (2017-2022)
    Table 30. Global Platelet-rich Plasma Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Platelet-rich Plasma Therapy Revenue Share by Application (2023-2028)
    Table 32. North America Platelet-rich Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Platelet-rich Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Platelet-rich Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Platelet-rich Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Platelet-rich Plasma Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Platelet-rich Plasma Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Platelet-rich Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Platelet-rich Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Platelet-rich Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Platelet-rich Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Platelet-rich Plasma Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Platelet-rich Plasma Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Platelet-rich Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Platelet-rich Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Platelet-rich Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Platelet-rich Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Platelet-rich Plasma Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Platelet-rich Plasma Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Platelet-rich Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Platelet-rich Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Platelet-rich Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Platelet-rich Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Platelet-rich Plasma Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Platelet-rich Plasma Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Platelet-rich Plasma Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Platelet-rich Plasma Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Platelet-rich Plasma Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Platelet-rich Plasma Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Platelet-rich Plasma Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Platelet-rich Plasma Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Terumo Company Details
    Table 63. Terumo Business Overview
    Table 64. Terumo Platelet-rich Plasma Therapy Product
    Table 65. Terumo Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 66. Terumo Recent Developments
    Table 67. Arthrex Company Details
    Table 68. Arthrex Business Overview
    Table 69. Arthrex Platelet-rich Plasma Therapy Product
    Table 70. Arthrex Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 71. Arthrex Recent Developments
    Table 72. Zimmer Biomet Company Details
    Table 73. Zimmer Biomet Business Overview
    Table 74. Zimmer Biomet Platelet-rich Plasma Therapy Product
    Table 75. Zimmer Biomet Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 76. Zimmer Biomet Recent Developments
    Table 77. DePuy Synthes Company Details
    Table 78. DePuy Synthes Business Overview
    Table 79. DePuy Synthes Platelet-rich Plasma Therapy Product
    Table 80. DePuy Synthes Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 81. DePuy Synthes Recent Developments
    Table 82. EmCyte Company Details
    Table 83. EmCyte Business Overview
    Table 84. EmCyte Platelet-rich Plasma Therapy Product
    Table 85. EmCyte Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 86. EmCyte Recent Developments
    Table 87. Regen Lab Company Details
    Table 88. Regen Lab Business Overview
    Table 89. Regen Lab Platelet-rich Plasma Therapy Product
    Table 90. Regen Lab Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 91. Regen Lab Recent Developments
    Table 92. ISTO Biologics Company Details
    Table 93. ISTO Biologics Business Overview
    Table 94. ISTO Biologics Platelet-rich Plasma Therapy Product
    Table 95. ISTO Biologics Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 96. ISTO Biologics Recent Developments
    Table 97. Cesca Therapeutics Company Details
    Table 98. Cesca Therapeutics Business Overview
    Table 99. Cesca Therapeutics Platelet-rich Plasma Therapy Product
    Table 100. Cesca Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 101. Cesca Therapeutics Recent Developments
    Table 102. Weigao Company Details
    Table 103. Weigao Business Overview
    Table 104. Weigao Platelet-rich Plasma Therapy Product
    Table 105. Weigao Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 106. Weigao Recent Developments
    Table 107. REV-MED Company Details
    Table 108. REV-MED Business Overview
    Table 109. REV-MED Platelet-rich Plasma Therapy Product
    Table 110. REV-MED Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 111. REV-MED Recent Developments
    Table 112. Nuo Therapeutics Company Details
    Table 113. Nuo Therapeutics Business Overview
    Table 114. Nuo Therapeutics Platelet-rich Plasma Therapy Product
    Table 115. Nuo Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2017-2022) & (US$ Million)
    Table 116. Nuo Therapeutics Recent Developments
    Table 117. Research Programs/Design for This Report
    Table 118. Key Data Information from Secondary Sources
    Table 119. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Platelet-rich Plasma Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Pure PRP Features
    Figure 3. Leucocyte-rich PRP Features
    Figure 4. Leukocyte-rich Fibrin (L-PRF) Features
    Figure 5. Global Platelet-rich Plasma Therapy Market Share by Application: 2021 VS 2028
    Figure 6. Orthopedic Case Studies
    Figure 7. Darmatology Case Studies
    Figure 8. Cardiac Muscle Injury Case Studies
    Figure 9. Dental Case Studies
    Figure 10. Nerve Injury Case Studies
    Figure 11. Others Case Studies
    Figure 12. Platelet-rich Plasma Therapy Report Years Considered
    Figure 13. Global Platelet-rich Plasma Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Platelet-rich Plasma Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Platelet-rich Plasma Therapy Market Share by Region: 2021 VS 2028
    Figure 16. Global Platelet-rich Plasma Therapy Market Share by Players in 2021
    Figure 17. Global Top Platelet-rich Plasma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Platelet-rich Plasma Therapy as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Platelet-rich Plasma Therapy Revenue in 2021
    Figure 19. North America Platelet-rich Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Platelet-rich Plasma Therapy Market Size Market Share by Type (2017-2028)
    Figure 21. North America Platelet-rich Plasma Therapy Market Size Market Share by Application (2017-2028)
    Figure 22. North America Platelet-rich Plasma Therapy Market Size Share by Country (2017-2028)
    Figure 23. United States Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Platelet-rich Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Platelet-rich Plasma Therapy Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Platelet-rich Plasma Therapy Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Platelet-rich Plasma Therapy Market Size Share by Country (2017-2028)
    Figure 29. Germany Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Platelet-rich Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Platelet-rich Plasma Therapy Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Platelet-rich Plasma Therapy Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Platelet-rich Plasma Therapy Market Size Share by Region (2017-2028)
    Figure 39. China Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Platelet-rich Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Platelet-rich Plasma Therapy Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Platelet-rich Plasma Therapy Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Platelet-rich Plasma Therapy Market Size Share by Country (2017-2028)
    Figure 49. Mexico Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Platelet-rich Plasma Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Platelet-rich Plasma Therapy Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Platelet-rich Plasma Therapy Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Platelet-rich Plasma Therapy Market Size Share by Country (2017-2028)
    Figure 55. Turkey Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Platelet-rich Plasma Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Terumo Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 59. Arthrex Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 60. Zimmer Biomet Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 61. DePuy Synthes Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 62. EmCyte Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 63. Regen Lab Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 64. ISTO Biologics Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 65. Cesca Therapeutics Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 66. Weigao Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 67. REV-MED Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 68. Nuo Therapeutics Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Medical Implantable Drug Infusion Pump - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-34A13945
Thu May 02 00:00:00 UTC 2024

Add to Cart

Pre-filled Flush Syringes(≤5ml) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-31G14124
Thu May 02 00:00:00 UTC 2024

Add to Cart

OTC Topical Antifungals - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-32D13978
Tue Apr 30 00:00:00 UTC 2024

Add to Cart

Fluoxetine Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-2J14387
Tue Apr 30 00:00:00 UTC 2024

Add to Cart